Skip to content
Eli Lilly and Company

Eli Lilly and Company technical analysis

LLYHealthcare Updated daily

Technical analysis of Eli Lilly and Company (stock) with the Montbon Method — Elliott Waves, moving averages and a 0–100 score.

What is Eli Lilly and Company

Eli Lilly and Company is a pharmaceutical company that discovers, develops, manufactures, and markets human pharmaceutical products on a global scale. The company operates in the cardiometabolic, oncology, immunology, and neurological disease sectors, with a significant presence in the United States, Europe, China, Japan, and other international markets.

Description generated automatically from public sources; it may be inaccurate or out of date.

Eli Lilly and Company: latest session data

Closing values for October 20, 2026, computed on the last 12 months of prices.

Close1,300.95 $
Change+4.89%
RSI (14)71.8
MACD24.224
ADX25.3
Volatility (ATR)2.83%
Volume vs 20-avg38%
12-month high1,304.31 $
12-month low893.98 $

Moving averages

21 sessions

1,188.17 $

+9.49%

50 sessions

1,182.71 $

+10.00%

200 sessions

1,079.78 $

+20.48%

Session levels

s2

1,225.88

Support

s1

1,233.11

Support

pivot

1,246.43

Pivot

r1

1,253.66

Resistance

r2

1,266.98

Resistance

How to read it

In the October 20, 2026 session Eli Lilly and Company closed higher at 1,300.95 $, +4.89% versus the previous session.

The price sits above every moving average observed: +9.49% against the 21-session average, +10.00% against the 50 and +20.48% against the 200.

The 14-period RSI reads 71.8, in overbought territory.

MACD stands at 24.224 against a signal line at 10.986: the histogram is positive (+13.237).

ADX reads 25.3, indicating a marked directionality.

Levels computed on the latest session place supports at 1,233.11 and 1,225.88 $ and resistances at 1,253.66 and 1,266.98 $, around a pivot of 1,246.43.

The average daily range (ATR) is 36.785 $, or 2.83% of price.

Turnover was 835K shares, 38% of the 20-session average.

Over the last twelve months the price ranged between 893.98 and 1,304.31 $, and today stands −0.26% from the period high.

Measures computed on closing prices. They describe the past; they are not forecasts.

Open the full analysis of Eli Lilly and Company

Score, Elliott Waves, moving averages and technical indicators — free, no card

If you're not registered we'll ask you to sign in (free), then open the LLY analysis.

How Montbon’s technical analysis works

Montbon analyses markets with Elliott Waves, multi-timeframe moving averages and a 0–100 score summarising the technical setup. It is an informational screening tool.

Elliott Waves

Wave counting to frame the price structure.

MTF moving averages

Moving averages across timeframes to read the trend.

0–100 score

A technical summary of the setup, updated daily.

Read the full Montbon Score methodology →

FAQ about Eli Lilly and Company

How is Eli Lilly and Company analysed technically?

Technical analysis of Eli Lilly and Company is based on price charts and indicators such as moving averages, RSI and MACD, to observe trend, momentum and volatility across different time horizons.

Which timeframes are used for Eli Lilly and Company?

The daily and weekly charts are typically used for medium-to-long-term trends, while intraday charts (for example 1-hour or 15-minute) are used for short-term movements.

What are Elliott Waves applied to Eli Lilly and Company?

Elliott Wave theory describes price moves as sequences of impulsive and corrective waves; applied to Eli Lilly and Company it helps frame the technical structure of the historical chart and is not a forecast.

Other tickers to analyse

Disclaimer. For informational purposes only; not financial advice or a recommendation. Montbon Analytics is not an authorised financial intermediary.

Are you an issuer and want a correction or removal? Write to info@montbon.com.